LentiStem Biotech

LentiStem Biotech is a Spanish biotechnology company specializing in the development of advanced lentiviral vector technologies for gene and cell therapy applications. The company's core innovation is the Lenti-G platform, which utilizes proprietary chimeric promoters to achieve highly regulated and tissue-specific transgene expression, overcoming common limitations such as gene silencing and off-target toxicity. LentiStem focuses on oncology and rare diseases, with a pipeline that includes next-generation CAR-T cell therapies designed for enhanced safety and efficacy. By providing both internal drug development and specialized viral vector services, the company aims to streamline the production of complex biologics for the global regenerative medicine market.